Dynamic regulation of Src-family kinases by CD45 in B cells

被引:37
作者
Shrivastava, P
Katagiri, T
Ogimoto, M
Mizuno, K
Yakura, H
机构
[1] Tokyo Metropolitan Inst Neurosci, Tokyo Metropolitan Org Med Res, Dept Immunol & Signal Transduct, Fuchu, Tokyo 1838526, Japan
[2] Toyama Med & Pharmaceut Univ, Dept Biol, Toyama, Japan
[3] Tokyo Metropolitan Univ, Grad Sch Sci, Hachioji, Tokyo, Japan
关键词
D O I
10.1182/blood-2003-03-0716
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CD45 is a key protein tyrosine phosphatase regulating Src-famlly protein tyrosine kinases (Src-PTKs) in lymphocytes; precisely how it exerts its effect remains controversial, however. We previously demonstrated that CD45 negatively regulates Lyn in the WEHI-231 B-cell line. Here we show that negative regulation by CD45 is physiologically significant in B cells and that some CD45 is constitutively associated with glycolipid-enriched microdomains (GEMs), where it inhibits Src-PTKs by dephosphorylating both the negative and the positive regulatory sites. Upon B-cell receptor (BCR) ligation, however, CD45 dissociates from GEMs within 30 seconds, inducing phosphorylation of 2 regulatory sites and activation of Src-PTKs, but subsequently reassociates with the GEMs within 15 minutes. Disruption of GEMs with methyl-beta-cyclodextrin results in abrogation of BCR-induced apoptosis in WEHI-231 cells, suggesting GEMs are critical to signals leading to the fate determination. We propose that the primary function of CD45 is inhibition of Src-PTKs and that the level of SrcPTK activation and the B-cell fate are determined in part by dynamic behavior of CD45 with respect to GEMs.
引用
收藏
页码:1425 / 1432
页数:8
相关论文
共 66 条
[1]   The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function [J].
Alexander, DR .
SEMINARS IN IMMUNOLOGY, 2000, 12 (04) :349-359
[2]   A requirement for lipid rafts in B cell receptor induced Ca2+ flux [J].
Aman, MJ ;
Ravichandran, KS .
CURRENT BIOLOGY, 2000, 10 (07) :393-396
[3]   CD45 and Src-family kinases: and now for something completely different [J].
Ashwell, JD ;
D'Oro, U .
IMMUNOLOGY TODAY, 1999, 20 (09) :412-416
[4]   Development of T-leukaemias in CD45 tyrosine phosphatase-deficient mutant lck mice [J].
Baker, M ;
Gamble, J ;
Tooze, R ;
Higgins, D ;
Yang, FT ;
O'Brien, PCM ;
Coleman, N ;
Pingel, S ;
Turner, M ;
Alexander, DR .
EMBO JOURNAL, 2000, 19 (17) :4644-4654
[5]   Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization [J].
Bilwes, AM ;
denHertog, J ;
Hunter, T ;
Noel, JP .
NATURE, 1996, 382 (6591) :555-559
[6]   Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase Csk and is involved in regulation of T cell activation [J].
Brdicka, T ;
Pavilstová, D ;
Leo, A ;
Bruyns, E ;
Korínek, V ;
Angelisová, P ;
Scherer, J ;
Shevchenko, A ;
Shevchenko, A ;
Hilgert, I ;
Cerny, J ;
Drbal, K ;
Kuramitsu, Y ;
Kornacker, B ;
Horejsí, V ;
Schraven, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (09) :1591-1604
[7]  
BROWN VK, 1994, J BIOL CHEM, V269, P17238
[8]  
BURNS CM, 1994, J BIOL CHEM, V269, P13594
[9]   CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4(+)CD8(+) thymocytes, and in B cell maturation [J].
Byth, KF ;
Conroy, LA ;
Howlett, S ;
Smith, AJH ;
May, J ;
Alexander, DR ;
Holmes, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1707-1718
[10]  
CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457